mevociclib   Click here for help

GtoPdb Ligand ID: 10467

Synonyms: compound 264 [WO2015154039A2] | SY-1365 | SY1365
Compound class: Synthetic organic
Comment: Mevociclib (SY-1365) is a cyclin-dependent kinase 7 (CDK7) inhibtor [1] that is claimed in Syros Pharmaceuticals' patent WO2015154039A2 [2]. It is being developed for potential to treat proliferative diseases. SY-1365 is a structural analogue of THZ1, and it covalently binds to the same cysteine residue located outside of the canonical kinase domain at which THZ1 binds.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 9
Hydrogen bond donors 4
Rotatable bonds 11
Topological polar surface area 127.93
Molecular weight 586.26
XLogP 3.98
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CN(CC=CC(=O)Nc1ccc(nc1)C(=O)NC1(C)CCCC(C1)Nc1ncc(c(n1)c1c[nH]c2c1cccc2)Cl)C
Isomeric SMILES CN(C/C=C/C(=O)Nc1ccc(nc1)C(=O)N[C@@]1(C)CCC[C@H](C1)Nc1ncc(c(n1)c1c[nH]c2c1cccc2)Cl)C
InChI InChI=1S/C31H35ClN8O2/c1-31(39-29(42)26-13-12-21(17-33-26)36-27(41)11-7-15-40(2)3)14-6-8-20(16-31)37-30-35-19-24(32)28(38-30)23-18-34-25-10-5-4-9-22(23)25/h4-5,7,9-13,17-20,34H,6,8,14-16H2,1-3H3,(H,36,41)(H,39,42)(H,35,37,38)/b11-7+/t20-,31+/m1/s1
InChI Key SCJNYBYSTCRPAO-LXBQGUBHSA-N
Bioactivity Comments
In a DiscoverX KINOMEscan screen 8 of 468 kinases including CDK7 were inhibited by >90% by 1 μM SY-1365. The 7 kinases other than CDK7 were RPS6KA6, DYRK1B, MAPK10, MAPK8, MAPK9, PIP4K2C and CDK15. However, in vitro inhibition may be less relevant in vivo for kinases that do not contain the appropriately positioned cysteine residue to which SY-1365 covalently binds.
Selectivity at enzymes
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
cyclin dependent kinase 7 Hs Inhibitor Inhibition >7.8 pKi - 1
pKi >7.8 (Ki <1.74x10-8 M) [1]